A recent paper featuring Origent’s work in ALS and published in Nature Biotechnology has now been featured as an Editor’s Choice article by the journal Science Translational Medicine.
Editor’s Choice articles are selected by the board of Associate Scientific Advisors at Science Translational Medicine, to highlight noteworthy contributions to the field of translational medicine. Each Associate Scientific Advisor on the panel is an outstanding early-career translational scientist who is nominated by principal investigators at CTSA recipient institutions, and serves a one-year term.
Origent applauds the hard work of its scientists Dr. Liuxia Wang and Guang Li, and the rest of the team behind this extremely valuable effort.